BR9611871A - Diaminopirimidinas composições farmacêuticas contendo as mesmas e seu uso como antibactericidas - Google Patents
Diaminopirimidinas composições farmacêuticas contendo as mesmas e seu uso como antibactericidasInfo
- Publication number
- BR9611871A BR9611871A BR9611871A BR9611871A BR9611871A BR 9611871 A BR9611871 A BR 9611871A BR 9611871 A BR9611871 A BR 9611871A BR 9611871 A BR9611871 A BR 9611871A BR 9611871 A BR9611871 A BR 9611871A
- Authority
- BR
- Brazil
- Prior art keywords
- diaminopyrimidines
- antibacterials
- pharmaceutical compositions
- compositions containing
- signifies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH342595 | 1995-12-04 | ||
PCT/EP1996/005151 WO1997020839A1 (en) | 1995-12-04 | 1996-11-22 | Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9611871A true BR9611871A (pt) | 1999-02-17 |
BR9611871B1 BR9611871B1 (pt) | 2010-11-03 |
Family
ID=4255709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9611871-7A BR9611871B1 (pt) | 1995-12-04 | 1996-11-22 | diaminopirimidinas, compostos intermediários para a sìntese das mesmas, bem como medicamento que as contém. |
Country Status (16)
Country | Link |
---|---|
US (1) | US5773446A (pt) |
EP (2) | EP0866791B1 (pt) |
JP (1) | JP3309340B2 (pt) |
KR (1) | KR100417207B1 (pt) |
CN (1) | CN1092194C (pt) |
AT (1) | ATE212629T1 (pt) |
AU (1) | AU708578B2 (pt) |
BR (1) | BR9611871B1 (pt) |
CA (1) | CA2238521C (pt) |
DE (1) | DE69618986T2 (pt) |
DK (1) | DK0866791T3 (pt) |
ES (1) | ES2169272T3 (pt) |
MX (1) | MX9804416A (pt) |
PT (1) | PT866791E (pt) |
TR (1) | TR199801014T2 (pt) |
WO (1) | WO1997020839A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW438796B (en) * | 1996-05-15 | 2001-06-07 | Hoffmann La Roche | 2,4-diaminopyrimidine derivatives, the manufacture process thereof, and the antibiotically-active pharmaceutical composition containing the same |
KR20020093966A (ko) * | 2000-04-27 | 2002-12-16 | 바실리어 파마슈티카 아게 | 항균제로서의 크로메닐메틸 피리미딘디아민 |
WO2002010156A1 (en) * | 2000-07-29 | 2002-02-07 | Arpida Ag | Benzofuran derivatives and their use as antibacterial agents |
WO2005014586A1 (en) * | 2003-08-08 | 2005-02-17 | Arpida Ag | Novel process for the preparation of 2h-chromenes |
EE200700051A (et) * | 2005-02-18 | 2007-12-17 | Arpida Ag | Meetod 2H-kromeeni valmistamiseks ning vahehendid |
US20090069357A1 (en) * | 2007-09-09 | 2009-03-12 | Protia, Llc | Deuterium-enriched iclaprim |
JP2011516509A (ja) * | 2008-04-08 | 2011-05-26 | アシノ ファーマ アーゲー | 水性医薬製剤 |
US7947293B2 (en) | 2008-04-08 | 2011-05-24 | Arpida Ag | Aqueous pharmaceutical formulation |
WO2017192744A1 (en) | 2016-05-04 | 2017-11-09 | Motif BioSciences Inc. | Systems and methods for treating bacterial infection |
WO2018144086A1 (en) * | 2016-11-11 | 2018-08-09 | Motif Biosciences, Inc. | Formulations, methods, kit, and dosage forms for treating bacterial infection |
CN110498812B (zh) * | 2018-05-17 | 2021-08-24 | 上海医药工业研究院 | 一种艾拉普林的中间体化合物的制备方法 |
CN110606831A (zh) * | 2018-06-14 | 2019-12-24 | 上海度德医药科技有限公司 | 一种Iclaprim的新中间体及其制备方法和应用 |
CN110818693B (zh) * | 2018-08-07 | 2023-06-02 | 上海度德医药科技有限公司 | 一种艾拉普林甲磺酸盐晶型b及其制备方法 |
WO2020161284A1 (en) | 2019-02-07 | 2020-08-13 | Sandoz Ag | Crystalline form of iclaprim mesylate |
CN109988156B (zh) * | 2019-03-12 | 2021-12-28 | 广东中科药物研究有限公司 | 一种氨基嘧啶化合物 |
CN113493461A (zh) * | 2020-04-01 | 2021-10-12 | 上海医药工业研究院 | 一种七元杂环化合物或其盐、其制备方法及应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4438267A (en) * | 1980-11-11 | 1984-03-20 | Daluge Susan M | Monoheteroring compounds and their use |
-
1996
- 1996-11-22 ES ES96939890T patent/ES2169272T3/es not_active Expired - Lifetime
- 1996-11-22 JP JP52092597A patent/JP3309340B2/ja not_active Expired - Fee Related
- 1996-11-22 BR BRPI9611871-7A patent/BR9611871B1/pt not_active IP Right Cessation
- 1996-11-22 CA CA002238521A patent/CA2238521C/en not_active Expired - Fee Related
- 1996-11-22 DK DK96939890T patent/DK0866791T3/da active
- 1996-11-22 EP EP96939890A patent/EP0866791B1/en not_active Expired - Lifetime
- 1996-11-22 PT PT96939890T patent/PT866791E/pt unknown
- 1996-11-22 TR TR1998/01014T patent/TR199801014T2/xx unknown
- 1996-11-22 CN CN96198783A patent/CN1092194C/zh not_active Expired - Fee Related
- 1996-11-22 AU AU76963/96A patent/AU708578B2/en not_active Ceased
- 1996-11-22 EP EP01117420A patent/EP1149834A1/en not_active Withdrawn
- 1996-11-22 AT AT96939890T patent/ATE212629T1/de active
- 1996-11-22 DE DE69618986T patent/DE69618986T2/de not_active Expired - Lifetime
- 1996-11-22 WO PCT/EP1996/005151 patent/WO1997020839A1/en active IP Right Grant
- 1996-11-22 KR KR10-1998-0704199A patent/KR100417207B1/ko not_active IP Right Cessation
- 1996-12-02 US US08/758,993 patent/US5773446A/en not_active Expired - Lifetime
-
1998
- 1998-06-03 MX MX9804416A patent/MX9804416A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2238521C (en) | 2005-08-16 |
JP2000501399A (ja) | 2000-02-08 |
AU708578B2 (en) | 1999-08-05 |
US5773446A (en) | 1998-06-30 |
CA2238521A1 (en) | 1997-06-12 |
ES2169272T3 (es) | 2002-07-01 |
KR19990071912A (ko) | 1999-09-27 |
BR9611871B1 (pt) | 2010-11-03 |
MX9804416A (es) | 1998-09-30 |
JP3309340B2 (ja) | 2002-07-29 |
KR100417207B1 (ko) | 2004-04-17 |
DE69618986T2 (de) | 2002-06-20 |
EP0866791A1 (en) | 1998-09-30 |
TR199801014T2 (xx) | 1998-09-21 |
EP0866791B1 (en) | 2002-01-30 |
AU7696396A (en) | 1997-06-27 |
CN1203600A (zh) | 1998-12-30 |
CN1092194C (zh) | 2002-10-09 |
DE69618986D1 (de) | 2002-03-14 |
ATE212629T1 (de) | 2002-02-15 |
DK0866791T3 (da) | 2002-04-22 |
WO1997020839A1 (en) | 1997-06-12 |
PT866791E (pt) | 2002-05-31 |
EP1149834A1 (en) | 2001-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9611871A (pt) | Diaminopirimidinas composições farmacêuticas contendo as mesmas e seu uso como antibactericidas | |
AU6194694A (en) | Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
IL109526A0 (en) | Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
AU2724292A (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid | |
MD1233C2 (ro) | Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora | |
IL114894A (en) | Pyrrolidine derivatives as endothelin antagonists, pharmaceutical compositions containing them, and their use in the preparation of medicaments | |
AU6542986A (en) | Pyridyl-methylthio substituted benzimidazoles | |
AU6194994A (en) | Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
NZ247201A (en) | Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions | |
MY115662A (en) | Novel compounds with analgesic effect | |
ATE290015T1 (de) | Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen | |
EP1473294A3 (en) | Substituted 1,3-oxathiolanes with antiviral properties | |
ES2160602T3 (es) | Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria. | |
ATE38991T1 (de) | In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
ATE132494T1 (de) | Substituierte 3-piperazinylalkyl 2,3-dihydro-4h- 1,3-benzoxazin-4-one, deren herstellung und verwendung in heilkunde | |
UA42733C2 (uk) | Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить | |
DE68927055D1 (de) | 2',5'-oligoadenylat-derivate zur verwendung als heilmittel | |
DE69030502D1 (de) | Cephalosporinverbindungen und deren herstellung | |
EP0487996B1 (de) | 3-substituierte Cephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
TR200003451T2 (tr) | Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları | |
DE69403110D1 (de) | Zyklische Angiopeptin Derivate, deren Herstellung und pharmazeutische Zusammensetzungen | |
IT1270122B (it) | 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Free format text: ARPIDA AG (CH) |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/11/2010, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25G | Requested change of headquarter approved |
Owner name: ARPIDA AG (CH) Free format text: ENDERECO ALTERADO CONFORME SOLICITADO NA PETICAO NO 020110076365/RJ DE 20/07/2011. |
|
B25A | Requested transfer of rights approved |
Owner name: ADIPRA AG (CH) Free format text: TRANSFERIDO DE: ARPIDA AG |
|
B25A | Requested transfer of rights approved |
Owner name: ACINO PHARMA AG (CH) Free format text: TRANSFERIDO POR FUSAO DE: ADIPRA AG |
|
B22O | Other matters related to patents and certificates of addition of invention: legal action concerning patent |
Free format text: INPI-52400.061204/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132250-71.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: ACINO PHARMA AG, ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, AGOURON PHARMACEUTICALA, ALCON LABORATORIES , ALZA CORPORATION. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 17A ANUIDADE. |
|
B19A | Notification of judicial decision: notification of judicial decision |
Free format text: INPI-52400.61574/13 SECAO JUDICIARIA DO RIO DE JANEIRO - 13A VARA FEDERAL PROCESSO NO. 2013.51.01.132250-7 AUTOR: INPI-INSTITUTO NACIONAL DE PROPRIEDADE INDUSTRIAL REU(S): AGOURON PHARMACEUTICALS,INC, ACINO PHARMA AG, ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, ALZA CORPORATION,ALCON LABORATORIES,INC . DECISAO: ISTO POSTO, HOMOLOGO OS ACORDOS FIRMADOS, JULGANDO EXTINTO O PROCESSO COM RESOLUCAO DE MERITO, FORTE NO ART.269,III DO CODIGO DE PROCESSO CIVIL. |